ArticleAnnals of translational medicine2022
A novel clinical dynamic stereopsis assessment based on autostereoscopic display system.
Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluation of a Novel Autostereoscopic Three-Dimensional System for Binocular Visual Function: A Comparative Validation Study.Journal of clinical medicine · 2026Article
- The impact of autostereoscopic screens on assessing depth perception.Annals of translational medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although it is recognized that dynamic stereopsis is vital in daily life, there is still room for improvement in assessment methods. A novel clinical dynamic stereopsis assessment method was created based on an autostereoscopic display system that did not require additional auxiliary glasses. This study evaluated the optical parameters and clinical performance of the autostereoscopic display system for clinical dynamic stereopsis assessment. Methods: The autostereoscopic dynamic stereopsis assessment device was based on a directional backlight technology. Experiment 1 was performed under the same environmental conditions to compare luminance, crosstalk, and spectrum between the autostereoscopic dynamic stereopsis assessment device and the conventional dynamic random-dot stereopsis measuring instrument. Experiment 2 was an observational, analytic, cross-sectional study involving 135 healthy participants, each of whom was asked to complete measurements on both the autostereoscopic and conventional devices in random order. Stereo acuity, operating time, acceptance, and visual fatigue scores were recorded for clinical evaluation. Results: The autostereoscopic device had brighter luminance (139 and 140 cd/m Conclusions: The autostereoscopic device has excellent functions in both optical parameters and clinical performance, and therefore has the potential to be applied and popularized in future assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.